Burns Matteson Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
5,068
-186
-4% -$38.7K 0.38% 38
2026
Q1
$1.11M Sell
5,254
-149
-3% -$32.1K 0.41% 34
2025
Q4
$1.11M Buy
5,403
+3,492
+183% +$657K 0.39% 39
2025
Q3
$300K Buy
+1,911
New +$295K 0.12% 148
2024
Q3
Sell
-3,181
Closed -$313K 167
2024
Q2
$313K Buy
+3,181
New +$324K 0.2% 105
2023
Q4
Sell
-6,245
Closed -$542K 140
2023
Q3
$542K Buy
+6,245
New +$565K 0.35% 84
2023
Q2
Sell
-7,632
Closed -$576K 146
2023
Q1
$576K Buy
+7,632
New +$576K 0.37% 74

Other funds holding CAH

Burns Matteson Capital Management's CAH Position: Q2 2026 in Review

Burns Matteson Capital Management reduced its Cardinal Health (CAH) stake by 3.5% in Q2 2026, selling an estimated $38.7K and leaving 5,068 shares worth $1.2M. The position accounts for 0.38% of the portfolio, ranked #38.

Burns Matteson Capital Management first reported a position in CAH in Q1 2023 and has held it in 7 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Burns Matteson Capital Management held 5,068 shares of Cardinal Health worth $1.2M as of Q2 2026.
  • Burns Matteson Capital Management sold 186 Cardinal Health shares in Q2 2026, an estimated $38.7K.
  • Cardinal Health made up 0.38% of Burns Matteson Capital Management's portfolio in Q2 2026, its #38 holding.
  • Burns Matteson Capital Management first reported a position in Cardinal Health in Q1 2023 and has held it in 7 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.